Sakkal. Expression of nitric oxide synthase isoforms in normal ventilatory and limb muscles. J. Appl. Physiol. 83(2): 348-353, 1997.-Nitric oxide (NO), an important messenger molecule with widespread actions, is synthesized by NO synthases (NOS). In this study, we investigated the correlation between fiber type and NOS activity among ventilatory and limb muscles of various species. We also assessed the presence of the three NOS isoforms in normal skeletal muscles and how various NOS inhibitors influence muscle NOS activity. NOS activity was detected in various muscles; however, NOS activity in rabbits and rats varied significantly among different muscles. Immunoblotting of muscle samples indicated the presence of both the neuronal NOS and the endothelial NOS isoforms but not the cytokine-inducible NOS isoform. However, these isoforms were expressed to different degrees in various muscles. Although the neuronal NOS isoform was detectable in the canine diaphragm, very weak expression was detected in rabbit, rat, and mouse diaphragms. The endothelial NOS isoform was detected in the rat and mouse diaphragms but not in the canine and rabbit diaphragms. We also found that N G -nitro-L-arginine methyl ester, 7-nitroindazole, and S-methylisothiourea were stronger inhibitors of muscle NOS activity than was aminoguanidine. These results indicate the presence of different degrees of constitutive NOS expression in normal ventilatory and limb muscles of various species. Our data also indicate that muscle NOS activity is not determined by fiber type distribution but by other not yet identified factors. The functional significance of this expression remains to be assessed. nitric oxide; skeletal muscle; ventilatory muscles; L-arginine NITRIC OXIDE SYNTHASE (NOS) is a flavin-and hemecontaining enzyme that catalyzes the NADPH-dependent conversion of L-arginine to nitric oxide (NO) and L-citrulline. Three main NOS isoforms have been identified thus far, two of which are constitutively expressed and were initially identified in the endothelial cells (ecNOS; type III) and brain cells (bNOS; type I), and the third is a cytokine-inducible (iNOS; type II) isoform (15).
NITRIC OXIDE SYNTHASE (NOS) is a flavin-and hemecontaining enzyme that catalyzes the NADPH-dependent conversion of L-arginine to nitric oxide (NO) and L-citrulline. Three main NOS isoforms have been identified thus far, two of which are constitutively expressed and were initially identified in the endothelial cells (ecNOS; type III) and brain cells (bNOS; type I), and the third is a cytokine-inducible (iNOS; type II) isoform (15) .
Under normal conditions, there is strong evidence that NO plays an important role in the regulation of skeletal muscle vascular tone in vivo. Scavengers of NO and inhibitors of NOS activity have been shown to elicit a significant increase in skeletal muscle vascular resistance and small arteriole tone (25, 30, 35) . These results suggest that NO is an important modulator of skeletal muscle vascular tone. Previous studies in our laboratory confirmed the significant role of NO in regulating diaphragmatic blood flow under basal conditions and in response to brief arterial occlusion (reactive hyperemia), phrenic nerve stimulation (active hyperemia), and alterations in arterial pressure (autoregulation) (7, 14, 32, 34) .
The exact isoform responsible for NO release in the majority of studies dealing with the role of NO in muscle blood flow was not identified but was assumed to be ecNOS. Until recently, this assumption was not challenged because no information was available regarding the expression of other NOS isoforms in cardiac and skeletal muscles. Nakane et al. (23) reported for the first time that bNOS mRNA is abundant in human skeletal muscle samples. These authors also found a single 160-kDa protein band that corresponded to bNOS monomer in human skeletal muscle samples. By comparison, no bNOS mRNA or protein could be detected in rat skeletal muscle samples. In a subsequent study, Kobzik et al. (16) reported that bNOS expression in skeletal muscle fibers is localized to muscle membranes of mainly type II fibers and that NOS activity, measured as the rate of L-citrulline production, varies significantly among rat muscles, with highest activity being in type II (glycolytic) muscle fibers. These findings suggest that muscle NOS activity is largely determined by bNOS activity. Kobzik et al. (16) also proposed that the synthesis of NO by striated muscle fiber exerts a negative influence on muscle force because inhibition of NOS activity resulted in a shift to the left in force-frequency relationships. In another study, in vitro incubated rat limb muscles were found to release NO that rises with increased muscle activity (2). More recently, Kobzik et al. (17) described the presence of ecNOS isoform in muscle fibers that have a high abundance of succinate dehydrogenase. This suggests that ecNOS activity is related to oxidative capacity of striated muscle fibers. Using immunohistochemistry, these authors reported that, unlike bNOS, ecNOS staining was more diffuse across the sarcoplasm. Despite these early reports, many questions regarding the relationship between muscle fiber type distribution and NOS activity, the presence or absence of inducible NOS isoform, and selective inhibition of muscle NOS activity by various NOS inhibitors remain unanswered. We undertook this study, therefore, to test a main hypothesis, namely, that skeletal muscle NOS activity correlates with fiber type distribution, i.e., the higher proportion of fast-twitch glycolytic fibers, the greater the NOS activity. We also examined whether total NOS activity is attributable to the constitutive expression of both neuronal and ecNOS isoforms and not to the cytokineinducible NOS isoform. Finally, we assessed the selec-tivity of various NOS inhibitors in inhibiting muscle NOS activity.
To achieve our objectives, we measured NOS activity (conversion of L-arginine to L-citrulline) in the presence of various NOS cofactors in limb and ventilatory muscles of various species. We sampled muscle tissues from rats, dogs, rabbits, and mice to study the correlation between fiber type and NOS activity over a wide range of fiber type distribution. We also assessed the effects of four different NOS inhibitors on muscle NOS activity. Finally, we performed immunoblotting by using selective antibodies for the three NOS isoforms to detect the presence of specific NOS isoforms and the molecular mass of NOS isoforms in various striated muscle samples.
MATERIALS AND METHODS
Materials. L-[2,3-3 H]arginine was obtained from DuPont. 7-Nitroindazole (7-NI) was obtained from Alexis Biochemicals (San Diego, CA). Primary monoclonal anti-bNOS, -ecNOS, and -iNOS antibodies were obtained from Transduction Laboratories (Lexington, KY). Secondary antibodies and chemiluminescence reagents were obtained from Amersham. The remaining agents were obtained from Sigma Chemical. Aminoguanidine, N G -nitro-L-arginine methyl ester (L-NAME), and S-methylisothiourea (SMT) were dissolved in phosphatebuffered saline, whereas 7-NI was dissolved in NaOH solution.
General animal preparation. Adult male mongrel dogs, Sprague-Dawley rats, New Zealand White rabbits, and C57/B6 mice were killed with an overdose of pentobarbital sodium, and ventilatory and limb muscles were exposed through surgical incisions, excised, cleaned of connective tissues, and quickly frozen in liquid nitrogen. The following rat limb muscles were examined: soleus, tibialis anterior, and middle portion of the lateral head of the gastrocnemius.
L-Citrulline assay. Muscle tissues were homogenized in six volumes (wt/vol) of homogenization buffer (10 mM N-2-hydroxyethylpiperazine-N8-2-ethanesulfonic acid buffer, 0.1 mM EDTA, 1 mM dithiothreitol, 0.32 mM sucrose, 1 mg/ml phenylmethylsulfonyl fluoride, 10 µg/ml leuopeptin, 10 µg/ml aprotinin, and 10 µg/ml pepstatin A, pH 7.4). Tissue homogenate (50 µl) was added to 10-ml prewarmed (37°C) tubes containing 100 µl of reaction buffer of the following composition (in mM): 50 KH 2 PO 4 , 60 valine, 1.5 NADPH, 10 FAD, 10 tetrahydrobiopterin (BH 4 ), 1.2 MgCl 2 , and 2 CaCl 2 , as well as 1 mg/ml bovine serum albumin, 1 µg/ml calmodulin, and 25 µl of 120 µM stock L-[2,3-3 H]arginine (150-200 counts · min 21 · pmol 21 ). The samples were incubated for 30 min at 37°C, and the reaction was terminated by the addition of 500 µl of cold (4°C) stop buffer (100 mM N-2-hydroxyethylpiperazine-N8-2-ethanesulfonic acid, 12 mM EDTA, pH 5.5). A similar procedure was used to assess Ca 21 /calmodulin-independent NOS activity, except that Ca 21 and calmodulin were omitted from the reaction buffer and 1.5 mM of ethylene glycol-bis(b-aminoethyl ether)-N,N,N8,N8-tetraacetic acid and EDTA were added. Background activity was measured by replacing tissue samples with 50 µl phosphate-buffered solution. This value was subtracted from tissue sample values to yield actual NOS activity. To obtain free L-[2,3-3 H]citrulline for the determination of enzyme activity, 2 ml of Dowex 50w resin (8% crosslinked, Na 1 form) were added to eliminate excess L-[2,3-3 H]-arginine. The supernatants were removed and examined for the presence of L- [2,3- In a few experiments, we assessed the effects of various NOS inhibitors on canine diaphragmatic NOS activity by adding NOS inhibitors directly to the reaction buffer at final concentrations of 1, 10, and 100 µM.
Immunoblotting. Frozen muscle samples were homogenized in 5 vol/wt buffer of the following composition: 50 mM tris(hydroxymethyl)aminomethane · HCl (pH 7.5), 1 mM EDTA, 5 mM b-mercaptoethanol, 10 µg/ml pepstatin A, 10 µg/ml aprotonin, 10 µg/ml leupeptin, and 100 µg/ml phenylmethylsulfonyl fluoride. Homogenate proteins (50 µg) were heated at 65°C for 30 min and then loaded on 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis slabs (Novex). Proteins were then electrically blotted onto polyvinylidene difluoride membrane, blocked with 5% nonfat dry milk, and subsequently incubated with 1:500 or 1:1,000 dilution of various monoclonal or polyclonal antibodies selective to various NOS isoforms. Proteins were detected with horseradish peroxidase-linked anti-mouse or anti-rabbit secondary antibodies and enhanced chemiluminescence reagents (Amersham). Pituitary, endothelial cell, and activated macrophage lysates were used as positive controls for bNOS, ecNOS, and iNOS, respectively. These lysates were supplied by Transduction Laboratories. Predetermined molecular mass standards (Bio-Rad) were used as markers.
Data analysis. Data are presented as means 6 SE. Differences in NOS activity between muscles or conditions were assessed by using two-way analysis of variance. P , 0.05 was considered significant. Figure 1 illustrates the mean values of NOS activity in various muscles (n 5 6 preparations for a given muscle). There were significant inter-and intraspecies differences in muscle NOS. Within a species, few differences in NOS activity were evident in various muscles in dogs and rabbits, but rat tissues showed greater differences in NOS activity in (Fig. 1) . Among rat muscle samples, total gastrocnemius NOS activity was significantly (P , 0.01) higher than in other muscles, whereas soleus muscle NOS activity was significantly lower than that in the diaphragm and tibialis anterior (Fig. 1) . No significant differences were observed between rat diaphragmatic and intercostal NOS activities. For the diaphragm and intercostal muscles, NOS activities in dog muscle samples were higher than those measured in rabbit, mouse, and rat muscle samples. Figure 1 shows that in all species, the majority of muscle NOS activity was dependent on the presence of Ca 21 and calmodulin.
RESULTS

Muscle NOS activity.
To test our main hypothesis, we correlated the proportions of type I and subgroups of type II fibers in various muscles (8, 11, 26) with total NOS activity. Classification of fibers into type I and type II is based on histochemical staining for myosin adenosinetriphosphatase activity, type I being slow-twitch fibers and type II, fast-twitch fibers. Analysis of single muscle flbers demonstrated that specific myosin heavy chains I, IIa, and IIb correspond to histochemical definitions of type I, IIA, and IIB fibers. In addition, histochemically defined type IID/X fibers are known to contain type IId myosin heavy chain. When all muscles of various species were pooled, no significant correlation between fiber type distribution and NOS activity was found (data not shown). The r values for correlation analysis between muscle NOS activity and proportion of type I, IIA, and IIB fibers were 0.24, 0.11, and 0.11, respectively (not significant). However, intraspecies analysis revealed that muscle NOS activity in the rat correlated positively with the proportion of type IID/X fibers and negatively with type I fibers (P , 0.01; Fig. 2) Immunoblotting. Anti-bNOS and -ecNOS antibodies detected protein bands of 160 and 130 kDa, respectively. The intensity of the bNOS band varied significantly among muscles of different species (Fig. 3A) . Canine ventilatory muscles showed relatively high bNOS band intensity, whereas weaker signals were detected in the rat, mouse, and rabbit diaphragms (Fig.   3A) . Very weak bNOS signals were detected in rabbit ventilatory muscles. There were also differences in bNOS expression among various muscles within a species. Figure 3B illustrates bNOS expression in rat muscles. Prominent bNOS expression was evident in the intercostal and gastrocnemius muscles, whereas weak bNOS expression was evident in the diaphragm and soleus muscles.
In addition to bNOS, there were differences in ecNOS expression among various muscles. Although rat and http://jap.physiology.org/ mouse diaphragms showed ecNOS expression, neither canine nor rabbit muscles showed any ecNOS expression (Fig. 4A) . Less variation in band intensity was detected with anti-ecNOS antibodies in rat muscles (Fig. 4B ). We were unable to detect iNOS protein in any of the muscles when a variety of anti-iNOS antibodies were used (data not shown).
Inhibition of NOS activity. Diaphragmatic NOS activity was strongly and dose dependently inhibited by 7-NI, L-NAME, or SMT (n 5 6, Table 1 ). Aminoguanidine, on the other hand, was a weak inhibitor of NOS activity (Table 1) .
DISCUSSION
The major finding of this study is that significant differences in mammalian skeletal muscle NOS activity exist within and between species. Analysis of NOS activity within species revealed that in the rat, muscle NOS activity correlated negatively with the proportion of type I fibers and positively with the proportion of type IID/X fibers. We also confirmed previous findings indicating that both ecNOS and bNOS isoforms are present in rat skeletal muscles (16, 17) , but canine and rabbit ventilatory muscles appear to lack ecNOS expression (Fig. 4A) . We also found that muscle NOS activity is inhibited strongly by L-arginine analogs 7-NI and SMT but weakly by aminoguanidine.
NOS expression in striated muscle fibers. The role of endothelial NO production in the regulation of ventilatory and limb muscle blood flow has been confirmed by numerous investigators (10, 14, 33, 35) . In none of these studies was the origin of NO release within skeletal muscles identified, but it was assumed to be the endothelial cell layer. With the most recent discovery of bNOS expression in skeletal muscle fiber, this assumption is being increasingly challenged. Nakane et al. (23) were the first to describe the existence of bNOS mRNA and protein in human skeletal muscle; however, the exact muscle studied in that report was not identified. In a later study, Kobzik et al. (16) demonstrated that rat skeletal muscles express the bNOS isoform, which is located in the sarcolemma of mainly type II fibers. Among the ventilatory muscles, only diaphragmatic NOS activity was measured by these authors. In other studies, in vitro incubated rat limb muscles were found to release NO that was suppressed by NOS inhibitors (2, 16).
The major finding of our study is that significant intra-and interspecies differences exist in muscle NOS activity. We would like to point out that we used a single published value of fiber type composition for a given muscle and correlated this value with muscle NOS activity (see RESULTS). One could, therefore, attribute the lack of a relationship between muscle NOS activity and muscle fiber type composition across species to the fact that significant differences in fiber type composition have been reported. However, when the data of Delp and Duan (8) (Fig. 2) remained highly significant. This finding suggests that muscle fiber composition is an important determinant of muscle NOS activity, at least in the rat. This conclusion supports an earlier one made by Kobzik et a1. (16) , who reported that muscle NOS activity in the rat correlated with the percentage of type II muscle fibers. These authors attributed this correlation to a relatively high expression of bNOS in type II fibers and suggested that bNOS activity represents a major part of total muscle NOS activity. Despite the similarity between our findings and those of Kobzik et al. (16) regarding rat muscles, there is a major difference in the experimental Values are means 6 SE; n 5 6 preparations. 7-NI, 7-nitroindazole; L-NAME, N G -nitro-L-arginine methyl ester; SMT, S-methylisothiourea; NOS, nitric oxide synthase. * P , 0.05; † P , 0.01 compared with control values. http://jap.physiology.org/ approach used in the two studies. While Kobzik et al. studied NOS activity in the particulate fraction of various skeletal muscles, whole cell homogenates were used in our study. The use of whole cell homogenates and the fact that we did not evaluate NOS isoform expression in the cytosolic vs. the particulate fraction of muscle homogenate limited our conclusion regarding the contribution of bNOS expression to total muscle NOS activity and whether bNOS expression correlates with muscle fiber type composition across species.
Another factor that might have contributed to interspecies differences in muscle NOS activity is the presence of ecNOS in muscle fibers (17) . Our results confirm the presence of this isoform in rat and mouse muscles; however, not all skeletal muscles express ecNOS. We failed to detect ecNOS expression in canine and rabbit muscles (Fig. 4A) . This finding was confirmed by using another polyclonal ecNOS antibody (Affinity BioReagents). Despite the observation of prominent ecNOS expression in rat and mouse skeletal muscles, the contribution of this isoform to NOS activity of whole cell homogenate and, by extension, the role of this isoform in determining the relationship between muscle NOS activity and fiber type distribution, remain unclear primarily because we did not identify the localization of ecNOS (particulate vs. cytosolic muscle fractions). It is also likely that differences in NOS activity among various muscles might not be due to diversities in NOS protein expression. This is because the availability of substrates and cofactors such as L-arginine, NADPH, and BH 4 is known to play a significant role in NOS activity. Variations in local concentrations of endogenous NOS inhibitors such as N G ,N G -dimethylarginine, and N G ,N8G-dimethylarginine, which are produced by the endothelium (31), could also explain differences in basal NOS activity in various muscles. Moreover, the rate of production of NO and L-citrulline by NOS is regulated in part by the local concentration of NO through a process known as autoinhibition (27) . It has also been established that the presence of NO scavengers such as superoxide anions (O 2 2 z) improves the rate of NO production by reducing autoinhibition. Conversely, the addition of superoxide dismutase reduces the rate of NO production by stabilizing NO and, hence, augmenting autoinhibition (27) . It is possible that inter-and intraspecies differences in local levels of O 2 2 z and superoxide dismutase in various skeletal muscles may contribute to the diversity in basal NOS activity. Clearly, more research is needed to elucidate the relevance of local and systemic factors in modulating muscle NOS activity in different species.
Inhibition of muscle NOS activity. L-Arginine analogs, the most commonly used NOS inhibitors, are known to interfere with L-arginine binding in the three NOS isoforms (19) . Our results indicate that L-NAME is capable of dose-dependent inhibition of diaphragmatic NOS activity. We also found that 7-NI is a potent inhibitor of muscle NOS activity. This compound is believed to target the heme group of NOS and also interferes with L-arginine binding (36) . In vivo and in vitro studies in rat tissues suggest that bNOS, but not ecNOS activity, is inhibited by 7-NI (21, 22) . The weak inhibitory influence of 7-NI on ecNOS activity has been attributed to poor uptake of this compound by intact endothelial cells (1) . Our results also indicate that aminoguanidine, a selective iNOS inhibitor (12, 20) , is a weak inhibitor of constitutive NOS activity of the ventilatory muscles. Only at a concentration of 1 mM (results not shown) did aminoguanidine partially inhibit muscle NOS activity. We attribute this partial inhibition to the effect of aminoguanidine on ecNOS activity (18) . Finally, Szabo et al. (29) proposed that SMT is at least 10-to 30-fold more potent as an iNOS inhibitor than any other NOS inhibitors. However, SMT is equipotent with methyl-L-arginine in inhibiting ecNOS activity in vitro and causes an increase in arterial blood pressure when injected in normal rats (29) . We found that SMT is similar to L-NAME in inhibiting muscle NOS activity.
Physiological implication. There is increasing evidence indicating that NO regulates diverse processes in skeletal muscle fibers. For instance, inhibition of muscle NOS activity has recently been shown to attenuate basal glucose transport (2) . There is also evidence that NO regulates muscle contractile force through guanosine 38, 58-cyclic monophosphate (cGMP)-dependent and cGMP-independent processes (16) . Agents that increase intracellular cGMP, such 8-bromo-cGMP, are known to reverse the influence of NOS inhibitors on muscle force (16) . It has also been proposed that NO depresses mitochondrial respiration in skeletal muscles (17) , cardiac myocytes (24), hepatocytes (28) , and vascular smooth muscle cells (9) . Inhibition of muscle mitochondrial cytochrome c oxidase by NO, which has been proposed to be the exact pathway through which NO inhibits mitochondrial respiration (6) , is likely to decrease cellular ATP and increases ADP, AMP, guanosine 58-diphosphate, and P i . These metabolites are known to regulate diverse cellular processes such as ion transport, protein synthesis, and muscle contraction. Finally, it has recently been described (15) that muscle bNOS protein interacts with dystrophin complex. In dystrophic muscles that lack the dystrophin complex, bNOS is no longer attached to the sarcolemma, suggesting that the dystrophin complex is critical for the tethering of bNOS to muscle membrane. These findings suggest that ecNOS and bNOS target different processes in skeletal muscle fibers. Whereas ecNOS targets mitochondrial functions, bNOS is expressed at the sarcolemma in close association with dystrophin.
Our results confirm that normal skeletal muscles of various species constitutively express both ecNOS and bNOS isoforms, but the degree of isoform expression varies significantly among different muscles. We also found that muscle NOS activity is not always related to the physiological function of a given muscle (e.g., lung ventilation in the case of the diaphragm and intercostal muscles), nor is it always correlated with fiber type composition. The reasons behind these differences in NOS expression and activity between different muscles need to be explored. 
